Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Yole Développement Announces New Technology & Market Analysis

Published: Monday, June 10, 2013
Last Updated: Sunday, June 09, 2013
Bookmark and Share
“Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets, a new report from Yole Développement.

Yole Développement has announced its new technology & market analysis: Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets.

With this report, Yole Développement proposes users to learn more about the microfluidic devices market. “The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018”, announces Benjamin Roussel, Technology & Market Analyst, Microfluidics & Medical Technologies at Yole Développement.

According to him, “This impressive 27% growth will be fueled mainly by pharmaceutical research and point-of-care applications”.

The microfluidic device market is expected to reach $5.7B by 2018!
Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.

By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies.

Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010 - 2012 and provides forecasts for 2013 - 2018.

Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production.

These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content.

The distinction between the microfluidic device market (first-level package device) and the microfluidic technology-based test market has also been calculated.

Discover the microfluidic market’s complex organization, broken down in nine segments
Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application.

For example, the added value of microfluidic devices in point-of-care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility.

Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.

This report provides a market segmentation covering the following applications: general dispensing - drug delivery - accurate dispensing - analytical devices - clinical and veterinary diagnostics - point-of-care testing - industrial and environmental testing - pharmaceutical and life science - microreaction technology.

Each application is presented with market data, trends/drivers, key players and technologies used.

Recent changes in the material mix provide new opportunities for polymer and silicon
Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics.

Whereas polymer is becoming the reference substrate for point-of-care applications, glass is still the main substrate for analytical devices. The penetration rate of each substrate vs. Microfluidic application is presented in this report.

Recently, the material mix has changed due to:
• The need to reduce device cost for some applications (i.e. switching from glass to polymer)
• The need to add new on-chip functions linked to emerging applications (i.e. growth of silicon use)

Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players.

This report provides an analysis of these new opportunities, in line with material mix changes.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Yole’s Analysts Believe in a Wide Adoption of Gas Sensors in Consumer Products
Company has announced that the gas sensor market is currently growing and will reach US$ 920 million in 2021.
Tuesday, February 23, 2016
Yole Développement Announces Foundation of BLUMORPHO
BLUMORPHO will create value from innovation.
Tuesday, February 17, 2015
Evaluate the Manufacturing Cost of MEMS Devices with Cost Analysis Tool
Yole Développement and its partner, System Plus Consulting propose a relevant tool to analysis MEMS manufacturing cost.
Thursday, September 10, 2009
Scientific News
Diagnostic Thread - Weaving the Future?
Researchers have created diagnostic threads that could pave the way for next-gen implantable and wearable diagnostics.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Adipose Analysis on Microfluidic Chips
Scientists have developed a microfluidic chip the works with minute liquid quantities to grow and study cells.
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
DNA Production Facility Begins Operation
Scientists mark the opening of the UK's first fully automated DNA construction and modification facility.
A “Micro Winery” That Makes Wine Continuously
An American professor, working in collaboration with EPFL, is developing a miniature device for producing wine non-stop and testing different fermentation processes.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
Tough New Hydrogel Hybrid Doesn’t Dry Out
Water-based material could be used to make artificial skin, longer-lasting contact lenses.
Lasers Carve the Path to Tissue Engineering
A new technique, developed at EPFL, combines microfluidics and lasers to guide cells in 3D space, overcoming major limitations to tissue engineering.
A Future Tool for Medicine, Food Safety
A new type of electronic sensor that might be used to quickly detect and classify bacteria for medical diagnostics and food safety has passed a key hurdle by distinguishing between dead and living bacteria cells.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!